TUMOUR NECROSIS FACTOR AS AN AUTOCRINE TUMOUR GROWTH FACTOR FOR CHRONIC B-CELL MALIGNANCIES
- 1 April 1988
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 331 (8592) , 969-971
- https://doi.org/10.1016/s0140-6736(88)91782-5
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- A two-site sandwich immunoradiometric assay of human lymphotoxin with monoclonal antibodies and its applicationsJournal of Immunological Methods, 1987
- Effect of tumor necrosis factor alpha on mitogen-activated human B cells.The Journal of Experimental Medicine, 1987
- Effects of human interleukin 1 and human tumor necrosis factor on human T lymphocyte colony formation.Journal of Clinical Investigation, 1987
- INTERFERONS IN CANCER THERAPY: A REAPPRAISALThe Lancet, 1987
- Human T cells from autoimmune and normal individuals can produce tumor necrosis factorEuropean Journal of Immunology, 1987
- Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1Nature, 1986
- Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors.The Journal of Experimental Medicine, 1986
- Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxinNature, 1984
- Comparison of in vitro cell cytotoxic assays for tumor necrosis factorJournal of Immunological Methods, 1984
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978